Activity Id186205Project Number7200AA22CA00002Implementing PartnerEnterprise - United States OtherActivity Start DateNAActivity End Date2026-11-30CountryWorldCountry CodeWLDRegionWorldFunding AgencyDepartment of StateManaging AgencyU.S. Agency for International DevelopmentFiscal Year2022Current Dollar Amount25000000International SectorHIVAIDSUSG SectorHIVAIDSDescriptionUSAID supports promising HIV prevention products that are in the later stages of development e.g. those completing safety and efficacy clinical trials. These are products with the potential to reach regulatory approval within five years and incorporate a range of desirable product characteristics identified through end-user research with women e.g. related to regimen duration reduced side effects discreetness etc.. Investments in promising products will be prioritized based on expected potential for impact on the HIV epidemic.
🔍 Key Information
📄
Tender Reference No.
490917710
📅
Publication Date
07 Jul 2023
💰
Estimated Value
N/A
🌐
Sector
Healthcare and Medicine
📅
Deadline
30 Nov 2026
📝
Notice Type
Projects
📍
Location
United states
📑
Contract Duration
3 Years 4 Months 23 Days
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.